Should serum voriconazole (Vori) levels be monitored in allogeneic hematopoietic stem cell transplant (HSCT) recipients?

被引：0
|
作者：
Trifilio, S
Ortiz, R
Pennick, G
Pi, J
Verma, A
Mehta, J
机构：
[1] Northwestern Univ, Chicago, IL 60611 USA
[2] Univ Texas, Hlth Sci Ctr, San Antonio, TX USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2004年 / 10卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
291
引用
收藏
页码：103 / 104
页数：2
相关论文
共 50 条
  • [21] Micafungin as anti-fungal prophylaxis in allogeneic hematopoietic stem cell transplant (HSCT) recipients
    Perruccio, K.
    Arcioni, F.
    Capolsini, I.
    Carotti, A.
    Cerri, C.
    Gurdo, G.
    Mastrodicasa, E.
    Minelli, O.
    Velardi, A.
    Caniglia, M.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S390 - S391
  • [22] IRON OVERLOAD IN HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT) RECIPIENTS
    Gonzalez Huerta, A. J.
    Buesa, C.
    Taboada, F.
    Gonzalez, S.
    Colado, E.
    Baniela, E.
    Carbajal, J.
    Rayon, C.
    Vallejo, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 448 - 449
  • [23] Vaccination of allogeneic hematopoietic stem cell transplant recipients-what should be considered?
    Hilgendorf, Inken
    Greinix, Hildegard
    Halter, Joerg
    Lawitschka, Anita
    Wolff, Daniel
    ANNALS OF HEMATOLOGY, 2017, 96 (04) : 701 - 702
  • [24] Antifungal prophylaxis with voriconazole in allogeneic hematopoietic stem cell transplantation recipients
    Magalhaes-Silverman, M
    Carter, T
    Hohl, R
    Shamsuddin, H
    Gingrich, R
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 89 - 89
  • [25] Different effects of lansoprazole and rabeprazole on the plasma voriconazole trough levels in allogeneic hematopoietic cell transplant recipients
    Yasu, Takeo
    Konuma, Takaaki
    Kato, Seiko
    Kurokawa, Yosuke
    Takahashi, Satoshi
    Tojo, Arinobu
    ANNALS OF HEMATOLOGY, 2016, 95 (11) : 1845 - 1851
  • [26] Different effects of lansoprazole and rabeprazole on the plasma voriconazole trough levels in allogeneic hematopoietic cell transplant recipients
    Takeo Yasu
    Takaaki Konuma
    Seiko Kato
    Yosuke Kurokawa
    Satoshi Takahashi
    Arinobu Tojo
    Annals of Hematology, 2016, 95 : 1845 - 1851
  • [27] Impact of Letermovir Prophylaxis on Voriconazole Exposure in Allogeneic Hematopoietic Cell Transplant Recipients
    Hamadeh, Issam S.
    Grunwald, Michael R.
    Martin, Allison
    Patel, Jai N.
    Shillingburg, Alexandra
    Kachur, Ekaterina
    Cook, Allene
    Karabinos, Allison
    Ai, Jing
    Knight, Thomas G.
    Ragon, Brittany K.
    Chojecki, Aleksander L.
    Shah, Nilay A.
    Sanikommu, Srinivasa R.
    Avalos, Belinda R.
    Copelan, Edward A.
    Shahid, Zainab
    BLOOD, 2020, 136
  • [28] Fusarium infection in hematopoietic stem cell transplant (HSCT) recipients.
    Nucci, M
    Marr, KA
    Queiroz-Telles, F
    Martins, CA
    Trabasso, P
    Costa, S
    Voltarelli, JC
    Colombo, AL
    Carter, RA
    Pasquini, R
    De Souza, C
    Anaissie, EJ
    BLOOD, 2002, 100 (11) : 440B - 440B
  • [29] Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients
    Trifilio, Steve
    Pennick, Gennethel
    Pi, Judy
    Zook, Jennifer
    Golf, Mary
    Kaniecki, Kimberley
    Singhal, Seema
    Williams, Stephanie
    Winter, Jane
    Tallman, Martin
    Gordon, Leo
    Frankfurt, Olga
    Evens, Andrew
    Mehta, Jayesh
    CANCER, 2007, 109 (08) : 1532 - 1535
  • [30] PROPHYLAXIS OF INVASIVE FUNGAL INFECTION WITH VORICONAZOLE IN HIGH-RISK ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
    Gutierrez, L.
    Martinez-Mugica, C.
    Gonzalez, A. J.
    Solano, J.
    Duenas, V.
    Palomo, P.
    Gonzalez, A. P.
    Gonzalez, S.
    Rayon, C.
    Vallejo, C.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S467 - S467
12345